Tech Product News

Publication
Article
Pharmacy Times
Volume 75
Issue 12

Inmar Reverse Logistics (Winston-Salem, NC) recently enhanced its invoice-link online invoice management tool with industry-first innovations that allow retailers to increase supply chain efficiency and significantly cut costs connected with product returns. The tool’s new return authorization (RA) functionality helps facilitate both quicker financial reconciliation and inventory expediting. The online automation offered by invoice-link for RA and product disposition aid in eliminating the labor-intensity of performing the processes manually, as well as the potential for errors. Among invoice-link’s features are online notifications and reminders, providing alerts to invoices awaiting authorization, which can be done online. The system also allows users to issue product disposition instructions online and access detailed tracking information. For more information, go to www.inmar.com.

Merck Manual iPhone App Puts Reference in the Palm of Users’ Hands

Agile Partners (New York, NY) has introduced a high-tech version of a medical reference that has stood the test of time. The Merck Manual has been a source of trusted health information for more than a century, and now its availability as an iPhone application (app) makes it conveniently portable. Developed for health care professionals on the go, The Merck Manual app provides information on thousands of diseases and treatments. It includes clinical approaches for each category of disorder, as well as specific guidance on patient evaluation and a “Find by Symptom” section that can be accessed right from the home screen. User-friendly, easy to navigate, and organized for quick accessibility to needed information, the app allows users to access a full index of its content, perform full text searches, resize text for easy reading, e-mail links, and bookmark favorites. Available through the iTunes App store, The Merck Manual app is designed for the iPhone and iPod touch. Visit http://store. apple.com/us and search for Merck Manual to learn more or purchase the app ($29.99).

Dose Control Puts Abuse on Lockdown While Promoting Adherence

Dose Control LLC (Winchester, KY) is set to launch its Dose Control prescription pill dispenser, a product aimed at managing access to medications with the potential for abuse and promoting adherence. Built to accommodate pills, tablets, or capsules, the Dose Control dispenser’s compact size makes it easily portable. The tamper-resistant, refillable, and programmable device locks internally without the use of a key and only dispenses pills to the patient at the prescribed and programmed rate. Dose Control can only be opened for refilling after all dosages have been accessed at their appropriate times. Audio and visual reminders for medication adherence are provided via an LED light, a display of the remaining time until dosages are due, and optional beeper feature. Able to be filled and refilled by patients, caregivers, or pharmacists, Dose Control comes with a patented design that enables it to be filled and refilled manually or with preconfigured blister packages at the pharmacy or pharmaceutical manufacturer level. Dose Control is slated for launch in the coming year. For more information, visit www.dosecontrol-llc.com.

FDA Widget Raises Red Flag for Flu Fraud

FDA (Silver Spring, MD) is offering a free Fraudulent H1N1 Products Widget that can easily be added to a Web site, portal home page, or blog to offer convenient access to search capability for swine flu products deemed fraudulent by the agency. Aimed at boosting awareness of questionable products whose manufacturers are simply looking to profit from the H1N1 problem, the widget’s content is updated automatically by the FDA, requiring no maintenance on the part of the user. Adding the application to one’s site, portal home page, or blog is simple. Go to http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm186340.htm and copy the html code, and then paste it directly into your Web page. â– 

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.